The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

Rheumatology (Oxford). 2011 Jul;50(7):1341-2. doi: 10.1093/rheumatology/ker146. Epub 2011 Apr 12.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Distribution
  • Aged
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy*
  • Bacterial Infections / epidemiology*
  • Bacterial Infections / etiology*
  • Bacterial Infections / physiopathology
  • Cohort Studies
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Interleukin 1 Receptor Antagonist Protein / adverse effects*
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use
  • Male
  • Middle Aged
  • Registries
  • Risk Assessment
  • Severity of Illness Index
  • Sex Distribution
  • Societies, Medical
  • Survival Rate
  • United Kingdom

Substances

  • Antirheumatic Agents
  • Interleukin 1 Receptor Antagonist Protein